高级检索
当前位置: 首页 > 详情页

Uncovering the Complexity Mechanism of Different Formulas Treatment for Rheumatoid Arthritis Based on a Novel Network Pharmacology Model.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan, China [2]Institute of IntegratedBioinformedicine and Translational Science, Hong Kong Baptist University, Hong Kong, Hong Kong [3]Institute of BasicResearch in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China [4]Department of Ultrasound,Eighth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China [5]Institute of Materia Medica, Chinese Academy ofMedical Sciences & Peking Union Medical College, Beijing, China [6]Department of Biochemistry and Molecular Biology,School of Basic Medical Sciences, Southern Medical University, Guangzhou, China [7]Guangdong Key Laboratory of SingleCell Technology and Application, Southern Medical University, Guangzhou, China
出处:
ISSN:

摘要:
Traditional Chinese medicine (TCM) with the characteristics of "multi-component-multi-target-multi-pathway" has obvious advantages in the prevention and treatment of complex diseases, especially in the aspects of "treating the same disease with different treatments". However, there are still some problems such as unclear substance basis and molecular mechanism of the effectiveness of formula. Network pharmacology is a new strategy based on system biology and poly-pharmacology, which could observe the intervention of drugs on disease networks at systematical and comprehensive level, and especially suitable for study of complex TCM systems. Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, causing articular and extra articular dysfunctions among patients, it could lead to irreversible joint damage or disability if left untreated. TCM formulas, Danggui-Sini-decoction (DSD), Guizhi-Fuzi-decoction (GFD), and Huangqi-Guizhi-Wuwu-Decoction (HGWD), et al., have been found successful in controlling RA in clinical applications. Here, a network pharmacology-based approach was established. With this model, key gene network motif with significant (KNMS) of three formulas were predicted, and the molecular mechanism of different formula in the treatment of rheumatoid arthritis (RA) was inferred based on these KNMSs. The results show that the KNMSs predicted by the model kept a high consistency with the corresponding C-T network in coverage of RA pathogenic genes, coverage of functional pathways and cumulative contribution of key nodes, which confirmed the reliability and accuracy of our proposed KNMS prediction strategy. All validated KNMSs of each RA therapy-related formula were employed to decode the mechanisms of different formulas treat the same disease. Finally, the key components in KNMSs of each formula were evaluated by in vitro experiments. Our proposed KNMS prediction and validation strategy provides methodological reference for interpreting the optimization of core components group and inference of molecular mechanism of formula in the treatment of complex diseases in TCM. Copyright © 2020 Wang, Gao, Lu, Li, Zhou, Qin, Du, Gao, Guan and Lu.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 2 区 药学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 药学
JCR分区:
出版当年[2018]版:
Q1 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan, China [2]Institute of IntegratedBioinformedicine and Translational Science, Hong Kong Baptist University, Hong Kong, Hong Kong
共同第一作者:
通讯作者:
通讯机构: [6]Department of Biochemistry and Molecular Biology,School of Basic Medical Sciences, Southern Medical University, Guangzhou, China [7]Guangdong Key Laboratory of SingleCell Technology and Application, Southern Medical University, Guangzhou, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号